Cargando…

Abnormal carbohydrate metabolism in a canine model for muscular dystrophy

The canine golden retriever muscular dystrophy (GRMD) model is the best animal model for studying Duchenne muscular dystrophy in humans. Considering the importance of glucose metabolism in the muscles, the existence of metabolic and endocrine alterations in a wide range of muscular dystrophies, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Amaral, Andressa R., Brunetto, Márcio A., Brólio, Marina P., Cima, Daniela S., Miglino, Maria A., Santos, João Paulo F., Ambrósio, Carlos E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705810/
https://www.ncbi.nlm.nih.gov/pubmed/29209496
http://dx.doi.org/10.1017/jns.2017.59
_version_ 1783282099760922624
author Amaral, Andressa R.
Brunetto, Márcio A.
Brólio, Marina P.
Cima, Daniela S.
Miglino, Maria A.
Santos, João Paulo F.
Ambrósio, Carlos E.
author_facet Amaral, Andressa R.
Brunetto, Márcio A.
Brólio, Marina P.
Cima, Daniela S.
Miglino, Maria A.
Santos, João Paulo F.
Ambrósio, Carlos E.
author_sort Amaral, Andressa R.
collection PubMed
description The canine golden retriever muscular dystrophy (GRMD) model is the best animal model for studying Duchenne muscular dystrophy in humans. Considering the importance of glucose metabolism in the muscles, the existence of metabolic and endocrine alterations in a wide range of muscular dystrophies, and the pre-existing relationship between blood insulin concentration and muscular atrophy, the present study aimed to evaluate the postprandial glucose and insulin response in GRMD dogs. A total of eighteen golden retriever dogs were randomly distributed into three experimental groups: healthy/control (G1), female GRMD carriers (G2), and male dogs affected by GRMD (G3). Higher plasma resting glucose levels (P = 0·0047) were seen in G2 and G3 compared with G1, as was the case for minimum (P = <0·0001), mean (P = 0·0002) and maximum (P = 0·0359) glucose values for G3 compared with G1. Fructosamine concentrations were in accordance with reference values found in the literature for dogs. Insulin levels were lower in G3 compared with G1 (P = 0·0065); however, there was no evidence of insulin resistance according to the homeostasis model assessment index values obtained. As for the evaluation of postprandial responses, fluctuations of glucose (P = 0·0007) and insulin (P = 0·0149) were observed in G1 and G2, while in G3 the values remained constant. The results allowed us to identify metabolic changes related to carbohydrate metabolism in GRMD dogs, highlighting the importance of adequate food management for these animals.
format Online
Article
Text
id pubmed-5705810
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-57058102017-12-05 Abnormal carbohydrate metabolism in a canine model for muscular dystrophy Amaral, Andressa R. Brunetto, Márcio A. Brólio, Marina P. Cima, Daniela S. Miglino, Maria A. Santos, João Paulo F. Ambrósio, Carlos E. J Nutr Sci Research Article The canine golden retriever muscular dystrophy (GRMD) model is the best animal model for studying Duchenne muscular dystrophy in humans. Considering the importance of glucose metabolism in the muscles, the existence of metabolic and endocrine alterations in a wide range of muscular dystrophies, and the pre-existing relationship between blood insulin concentration and muscular atrophy, the present study aimed to evaluate the postprandial glucose and insulin response in GRMD dogs. A total of eighteen golden retriever dogs were randomly distributed into three experimental groups: healthy/control (G1), female GRMD carriers (G2), and male dogs affected by GRMD (G3). Higher plasma resting glucose levels (P = 0·0047) were seen in G2 and G3 compared with G1, as was the case for minimum (P = <0·0001), mean (P = 0·0002) and maximum (P = 0·0359) glucose values for G3 compared with G1. Fructosamine concentrations were in accordance with reference values found in the literature for dogs. Insulin levels were lower in G3 compared with G1 (P = 0·0065); however, there was no evidence of insulin resistance according to the homeostasis model assessment index values obtained. As for the evaluation of postprandial responses, fluctuations of glucose (P = 0·0007) and insulin (P = 0·0149) were observed in G1 and G2, while in G3 the values remained constant. The results allowed us to identify metabolic changes related to carbohydrate metabolism in GRMD dogs, highlighting the importance of adequate food management for these animals. Cambridge University Press 2017-11-23 /pmc/articles/PMC5705810/ /pubmed/29209496 http://dx.doi.org/10.1017/jns.2017.59 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Amaral, Andressa R.
Brunetto, Márcio A.
Brólio, Marina P.
Cima, Daniela S.
Miglino, Maria A.
Santos, João Paulo F.
Ambrósio, Carlos E.
Abnormal carbohydrate metabolism in a canine model for muscular dystrophy
title Abnormal carbohydrate metabolism in a canine model for muscular dystrophy
title_full Abnormal carbohydrate metabolism in a canine model for muscular dystrophy
title_fullStr Abnormal carbohydrate metabolism in a canine model for muscular dystrophy
title_full_unstemmed Abnormal carbohydrate metabolism in a canine model for muscular dystrophy
title_short Abnormal carbohydrate metabolism in a canine model for muscular dystrophy
title_sort abnormal carbohydrate metabolism in a canine model for muscular dystrophy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705810/
https://www.ncbi.nlm.nih.gov/pubmed/29209496
http://dx.doi.org/10.1017/jns.2017.59
work_keys_str_mv AT amaralandressar abnormalcarbohydratemetabolisminacaninemodelformusculardystrophy
AT brunettomarcioa abnormalcarbohydratemetabolisminacaninemodelformusculardystrophy
AT broliomarinap abnormalcarbohydratemetabolisminacaninemodelformusculardystrophy
AT cimadanielas abnormalcarbohydratemetabolisminacaninemodelformusculardystrophy
AT miglinomariaa abnormalcarbohydratemetabolisminacaninemodelformusculardystrophy
AT santosjoaopaulof abnormalcarbohydratemetabolisminacaninemodelformusculardystrophy
AT ambrosiocarlose abnormalcarbohydratemetabolisminacaninemodelformusculardystrophy